Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Correction

Corrections

DOI:  Published November 2002
  • Article
  • Info & Metrics
  • PDF
Loading

Re: Atkinson et al.: Overnight Urinary Isoflavone Excretion in a Population of Women Living in the United States, and Its Relationship to Isoflavone Intake. 11: 253–260, March 2002 .

We wish to call attention to an error in the units given for isoflavone intakes and in the estimation of weekly isoflavone intakes according to the diet recall. The units for isoflavone intakes determined using both assessment methods should be in μmol, not nmol (Table 2, page 257; Table 4, page 259; Figure 1, page 259; and in the text of the methods and results). The last sentence of paragraph two on page 255 should read “Weekly isoflavone intakes according to the diet recall were estimated as mean intake over the 2 days x 7”, and the data in Table 2 column 5 (“Estimated weekly intake”), page 257, should be as follows: “Soy consumers—Genistein 208.1 [183.6−235.8], range 13.9−5270.4; Daidzein 155.3 [137.0−176.0], range 9.2−3898.4. All women−Genistein 2.1 [1.4−2.9], range 0−5270.4; Daidzein 1.9 [1.3−2.6], range 0−3898.4.” These data were not used in any subsequent calculations and this change does not alter the discussion or conclusions.

Re: Zheng et al: Haplotypes of Two Variants in p16(CDKN2/MTS-1/INK4a) Exon 3 and Risk of Squamous Cell Carcinoma of the Head and Neck: A Case-Control Study. 11: 640–645, July 2002 .

  1. Note the following sentence in line 4 of paragraph 3 of the Introduction on page 640: “… furthermore, C580T polymorphism co-segregates with the C74A polymorphism of intron 1 of CDKN2B (18).” should read as “… furthermore, C540Gpolymorphism co-segregates with the C74A polymorphism of intron 1 of CDKN2B (18).”

    (Note: The change is C580T to C540G)

  2. Note the following sentence in paragraph 2 of the Materials and Methods on page 641: “For PCR, the previously described primers (17) were used: 5′-GCC TGT TTT CTT TCT GCC CTC TG-3′ (sense)…” should read as “For PCR, the previously described primers (18) were used: 5′-GCC TGT TTT CTT TCT GCC CTC TG-3′ (sense; confirmed by the reported sequences: accession number U12820)…”

    (Note: The changes are 17 to 18 and the addition of “confirmed by the reported sequences: accession number U12820.”

    We believe the major two important findings in our paper are not affected in any way by these two misquotes.

And please note the correct author names to an article in the October Issue:

Buccal Cell DNA Yield, Quality, and Collection Costs: Comparison of Methods for Large-scale Studies Irena B. King, Jessie Satia-Abouta, Mark D. Thornquist, Jeannette Bigler, Ruth E. Patterson, Alan R. Kristal, Ann L. Shattuck, John D. Potter, and Emily White……. . 1130

PreviousNext
Back to top
November 2002
Volume 11, Issue 11
  • Table of Contents

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Corrections
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Corrections
Cancer Epidemiol Biomarkers Prev November 1 2002 (11) (11) 1511;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Corrections
Cancer Epidemiol Biomarkers Prev November 1 2002 (11) (11) 1511;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Correction: The Effects of Residential Segregation and Neighborhood Characteristics on Surgery and Survival in Patients with Early-Stage Non–Small Cell Lung Cancer
  • Correction: Carnitine and Cardiac Dysfunction in Childhood Cancer Survivors Treated with Anthracyclines
  • Correction: Vitamin D–Related Genetic Variants, Interactions with Vitamin D Exposure, and Breast Cancer Risk among Caucasian Women in Ontario
Show more Correction
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement